Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1947 Jan 31;85(2):175–186. doi: 10.1084/jem.85.2.175

THE THERAPEUTIC ACTIVITY OF PENICILLINS F, G, K, AND X IN EXPERIMENTAL INFECTIONS WITH PNEUMOCOCCUS TYPE I AND STREPTOCOCCUS PYOGENES

Harry Eagle 1; With the Technical Assistance of Arlyne D. Musselman1
PMCID: PMC2135693  PMID: 19871606

Abstract

1. The relative bactericidal activities of penicillins F, G, K, and X against Type I pneumococcus in vitro were 60, 100, 180, and 135. The corresponding activities against Streptococcus pyogenes, strain C-203, were 75, 100, 115, and 145, respectively. 2. The total curative doses (CD50) of penicillins F, G, K, and X in pneumococcal infections of white mice (ten injections at 3 hour intervals) were 4.6, 3.8, 20, and 2.4 mg. per kg., respectively, or relative activities of 83, 100, 19, and 160, referred to G as 100. 3. The corresponding curative doses in streptococcal infections of white mice were 2.6, 1.3, 14.0, and 0.5 mg. per kg., or relative activities of 50, 100, 9, and 260. 4. Penicillin K was therefore one-tenth as active in vivo as would be implied by its bactericidal activity in vitro. This probably reflects its rapid inactivation in vivo, evidenced by the low and evanescent blood levels observed in both rabbits and man, and the low urinary recovery of this species of penicillin. 5. Penicillin X was significantly more active therapeutically than its bactericidal activity in vitro would imply. This probably reflects its slower inactivation in vivo, evidenced by the somewhat higher and more prolonged blood levels afforded by this penicillin in comparison with penicillin G. Judged by the mouse infections with the strains here used, penicillin X is the penicillin of choice in the treatment of infections with pneumococcus Type I and hemolytic streptococci. 6. The curative dose of penicillin in streptococcal and pneumococcal infections paralleled the varying susceptibility of these organisms to penicillin in vitro.

Full Text

The Full Text of this article is available as a PDF (622.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coghill R. D., Osterberg A. E., Hazel G. R. The Relative Effectiveness of Pure Penicillins G, X, and K. Science. 1946 Jun 14;103(2685):709–710. doi: 10.1126/science.103.2685.709. [DOI] [PubMed] [Google Scholar]
  2. Eagle H., Musselman A. The Low Therapeutic Activity of Penicillin K Relative to That of Penicillins F, G, and X, and Its Pharmacological Basis. Science. 1946 May 17;103(2681):618–620. doi: 10.1126/science.103.2681.618. [DOI] [PubMed] [Google Scholar]
  3. Eagle H., Technical Assistance of Arlyne D. Musselman THE INACTIVATION OF PENICILLINS F, G, K, AND X BY HUMAN AND RABBIT SERUM. J Exp Med. 1947 Jan 31;85(2):141–161. doi: 10.1084/jem.85.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eagle H., Technical Assistance of Arlyne D. Musselman THE VARYING BLOOD LEVELS AFFORDED BY PENICILLINS F, G, K, AND X IN RABBITS AND MAN. J Exp Med. 1947 Jan 31;85(2):163–173. doi: 10.1084/jem.85.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eagle H. The Relative Activity of Penicillins F, G, K, and X Against Spirochetes and Streptococci in Vitro. J Bacteriol. 1946 Jul;52(1):81–88. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES